JP2004526758A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526758A5
JP2004526758A5 JP2002580892A JP2002580892A JP2004526758A5 JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5 JP 2002580892 A JP2002580892 A JP 2002580892A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5
Authority
JP
Japan
Prior art keywords
tsp
composition
angiogenesis inhibitor
cosmetic
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526758A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/011403 external-priority patent/WO2002083088A1/en
Publication of JP2004526758A publication Critical patent/JP2004526758A/ja
Publication of JP2004526758A5 publication Critical patent/JP2004526758A5/ja
Pending legal-status Critical Current

Links

JP2002580892A 2001-04-13 2002-04-11 紫外線ｂにより誘導される皮膚損傷の予防法 Pending JP2004526758A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Publications (2)

Publication Number Publication Date
JP2004526758A JP2004526758A (ja) 2004-09-02
JP2004526758A5 true JP2004526758A5 (https=) 2005-08-18

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580892A Pending JP2004526758A (ja) 2001-04-13 2002-04-11 紫外線ｂにより誘導される皮膚損傷の予防法

Country Status (8)

Country Link
US (1) US6712617B2 (https=)
EP (1) EP1377253A4 (https=)
JP (1) JP2004526758A (https=)
KR (2) KR20040021598A (https=)
CN (1) CN100340287C (https=)
CA (1) CA2446093A1 (https=)
TW (1) TWI233361B (https=)
WO (1) WO2002083088A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
EP1559429A4 (en) * 2002-06-25 2009-09-09 Shiseido Co Ltd AGAIN AGING AGING
CA2494536C (en) * 2002-07-31 2011-10-04 Mercian Corporation A 12-membered ring macrolide active substance
JP4459051B2 (ja) * 2002-07-31 2010-04-28 メルシャン株式会社 新規生理活性物質
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
BR0316746A (pt) * 2002-11-29 2005-10-18 Mercian Corp Método de produção do composto macrolida 11107d, linhagem streptomyces sp.ab-1704 (ferm bp-8551), linhagem mortierella sp. f1529 (ferm bp-8547) ou linhagem f-1530 (ferm bp-8548), e linhagem ab-1896 (ferm bp-8550)
US20050281761A1 (en) * 2004-04-01 2005-12-22 Michael Detmar Methods of preventing UVB-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
EP3340511B1 (en) 2004-10-12 2022-11-30 TQ Delta, LLC Resource sharing in a telecommunications enviroment
US9084734B2 (en) 2005-05-05 2015-07-21 Danisco Us Inc. Peptide personal care compositions and methods for their use
EP1938827A4 (en) * 2005-09-16 2010-07-21 Shiseido Co Ltd NEW HEMMER OF THE EXPRESSION OF VASCULAR ENDOTHEL GROWTH FACTOR
TWI428143B (zh) 2006-01-18 2014-03-01 Gen Hospital Corp 增加淋巴功能之方法
AU2007257055A1 (en) 2006-04-12 2007-12-13 Aware, Inc. Packet retransmission and memory sharing
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
WO2008020584A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
US7790887B2 (en) * 2007-01-29 2010-09-07 Eisai R&D Management Co., Ltd. Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
CN101970012A (zh) 2007-09-14 2011-02-09 日东电工株式会社 药物载体
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
US20240189397A1 (en) * 2019-12-24 2024-06-13 Juvena Therapeutics, Inc. Heparin-Associated Polypeptides and Uses Thereof
CN115379850A (zh) 2019-12-24 2022-11-22 裘美娜治疗公司 再生性多肽及其用途
WO2022271466A1 (en) 2021-06-21 2022-12-29 Juvena Therapeutics, Inc. Regenerative polypeptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
BR9809691A (pt) * 1997-05-27 2000-10-03 Sembiosys Genetics Inc Usos de substâncias de óleo
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
EP1171151A4 (en) * 1999-03-31 2004-08-04 Gen Hospital Corp THROMBOSPONDIN-2 AND THEIR USE
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Similar Documents

Publication Publication Date Title
JP2004526758A5 (https=)
KR100924476B1 (ko) 국소 글리코피롤레이트 제품
JP2002532432A5 (https=)
ES2310010T3 (es) Composiciones viscosas que contienen dioxido de carbono.
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
JP2004505007A5 (https=)
DE799037T1 (de) Verfahren und mittel zur behandlung der allergischen rhinitis und anderer erkrankungen mittels descarboethoxyloratadin
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
BRPI0608951A2 (pt) composições e método para o tratamento de acne
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
Stagnone Superficial peeling
RU2002121546A (ru) Вещества, предназначенные для лечения псориаза
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
CA2448829C (en) Preparation for the removal of abnormal keratinous material
JP5643872B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
AU709422B2 (en) Method for topical treatment of scar tissue and related tissue reaction to trauma
JPH05194140A (ja) 硫黄原子を持つアミノ酸を含有する爪処置用組成物
US20110160166A1 (en) Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
RU2002129298A (ru) Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера
JP2013177460A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2008543902A5 (https=)
MX2023009424A (es) Composicion antitranspirante.
ZEGARELLI et al. Triamcinolone Acetonide in the Treatment of Erosive Lichen Planus of the Oral Mucosae: Preliminary Report